00867 康哲藥業
按盘价 
7.800 +0.040 (+0.515%) 盈利能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 资产回报率 (%) | 13.532% | 19.421% | 21.168% | 21.200% | 18.090% |
| 股东资金回报率 (%) | 15.948% | 23.839% | 25.371% | 24.678% | 21.995% |
| 资本运用回报率 (%) | 15.310% | 21.907% | 21.982% | 21.464% | 20.375% |
边际利润分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 毛利率 (%) | 76.238% | 76.892% | 74.928% | 73.917% | 74.853% |
| 未计利息、税项、折旧及摊销前利润率 (%) | 34.009% | 42.278% | 42.550% | 40.845% | 42.672% |
| 税前边际利润率 (%) | 35.863% | 41.122% | 41.460% | 40.543% | 40.959% |
| 纯利率 (%) | 29.962% | 35.616% | 36.192% | 36.430% | 32.282% |
变现能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 流动比率 (X) | 4.293 X | 3.069 X | 3.546 X | 5.459 X | 2.295 X |
| 速动比率 (X) | 3.981 X | 2.903 X | 3.319 X | 5.041 X | 2.032 X |
财务杠杆分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 总负债 / 总资产比率 (%) | 12.264% | 16.991% | 18.730% | 12.584% | 14.814% |
| 总债项 / 总资产比率 (%) | 7.342% | 10.210% | 10.832% | 4.725% | 6.390% |
| 净债项 / 总资产比率 (%) | -16.972% | -14.441% | -10.586% | -16.284% | -5.830% |
| 总债项 / 股东资金比率 (%) | 8.387% | 12.425% | 13.427% | 5.439% | 7.535% |
| 长期债项 / 股东资金比率 (%) | 0.107% | 0.092% | 4.639% | 5.373% | 0.111% |
| 净债项 / 股东资金比率 (%) | -19.390% | -17.573% | -13.122% | -18.744% | -6.875% |
| 净现金 / (债项) ($) | 30.09亿 | 25.64亿 | 16.73亿 | 20.68亿 | 6.51亿 |
| 每股净现金 / (债项) ($) | 1.227 | 1.046 | 0.681 | 0.837 | 0.263 |
| 总债项 / 资本运用比率 (%) | 8.301% | 12.185% | 12.474% | 5.091% | 7.417% |
| 利息盈利率 (X) | 63.134 X | 77.658 X | 123.271 X | 103.329 X | 45.222 X |
营运效率分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 存货周转率日数 (日) | 106.852日 | 81.976日 | 74.545日 | 79.404日 | 100.578日 |
| 应收贸易帐周转率日数 (日) | 69.219日 | 71.018日 | 73.179日 | 76.453日 | 89.789日 |
| 应付贸易帐周转率日数 (日) | 7.280日 | 6.460日 | 6.145日 | 4.699日 | 4.512日 |
| 备注： | 实时报价更新时间为12/11/2024 09:32 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) (千) | RMB 910,426 |
| 增长率 | -52.608% |
| 每股盈利/(亏损) | RMB 0.373 |
| 每股账面资产净值 (¥) | RMB 6.524 |